235 related articles for article (PubMed ID: 27171432)
41. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
42. The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells.
Hu S; Li X; Xu R; Ye L; Kong H; Zeng X; Wang H; Xie W
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):528-35. PubMed ID: 27084520
[TBL] [Abstract][Full Text] [Related]
43. Autophagy and apoptotic machinery caused by Polygonum cuspidatum extract in cisplatin‑resistant human oral cancer CAR cells.
Wang YL; Horng CT; Hsieh MT; Chen HC; Huang YS; Yang JS; Wang GK; Chiang JH; Chen HH; Lu CC; Chen FA
Oncol Rep; 2019 Apr; 41(4):2549-2557. PubMed ID: 30720102
[TBL] [Abstract][Full Text] [Related]
44. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
Greco FA; Stroup SL; Gray JR; Hainsworth JD
J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
[TBL] [Abstract][Full Text] [Related]
45. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
[TBL] [Abstract][Full Text] [Related]
46. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
47. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
48. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549.
Shen F; Gai J; Xing J; Guan J; Fu L; Li Q
Biochem Biophys Res Commun; 2018 Jan; 495(1):1158-1166. PubMed ID: 29175207
[TBL] [Abstract][Full Text] [Related]
49. Role of autophagy in apoptosis induction by methylene chloride extracts of Mori cortex in NCI-H460 human lung carcinoma cells.
Park SH; Chi GY; Eom HS; Kim GY; Hyun JW; Kim WJ; Lee SJ; Yoo YH; Choi YH
Int J Oncol; 2012 Jun; 40(6):1929-40. PubMed ID: 22367066
[TBL] [Abstract][Full Text] [Related]
50. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
[TBL] [Abstract][Full Text] [Related]
51. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
Zhou Y; Pan DS; Shan S; Zhu JZ; Zhang K; Yue XP; Nie LP; Wan J; Lu XP; Zhang W; Ning ZQ
Biomed Pharmacother; 2014 May; 68(4):483-91. PubMed ID: 24721323
[TBL] [Abstract][Full Text] [Related]
52. Green tea extract induces protective autophagy in A549 non-small lung cancer cell line.
Izdebska M; Klimaszewska-Wiśniewska A; Hałas M; Gagat M; Grzanka A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1478-84. PubMed ID: 27259219
[TBL] [Abstract][Full Text] [Related]
53. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.
Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM
Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186
[TBL] [Abstract][Full Text] [Related]
54. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
55. GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.
Hsin IL; Ou CC; Wu MF; Jan MS; Hsiao YM; Lin CH; Ko JL
Mol Pharm; 2015 May; 12(5):1534-43. PubMed ID: 25811903
[TBL] [Abstract][Full Text] [Related]
56. [Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].
Liu L; Bian K
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3216-20. PubMed ID: 25522600
[TBL] [Abstract][Full Text] [Related]
57. Cypripedin, a phenanthrenequinone from Dendrobium densiflorum, sensitizes non-small cell lung cancer H460 cells to cisplatin-mediated apoptosis.
Wattanathamsan O; Treesuwan S; Sritularak B; Pongrakhananon V
J Nat Med; 2018 Mar; 72(2):503-513. PubMed ID: 29426985
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment.
Li Q; Yang Z; Chen M; Liu Y
Int J Mol Med; 2016 Apr; 37(4):1067-74. PubMed ID: 26936095
[TBL] [Abstract][Full Text] [Related]
59. Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.
Gatzemeier U; von Pawel J; Gottfried M; ten Velde GP; Mattson K; de Marinis F; Harper P; Salvati F; Robinet G; Lucenti A; Bogaerts J; Gallant G
J Clin Oncol; 2000 Oct; 18(19):3390-9. PubMed ID: 11013280
[TBL] [Abstract][Full Text] [Related]
60. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.
Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA
Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
